Does Rallies show 13F holders for SILO?

Yes. Rallies tracks hedge fund and 13F ownership data for SILO, including fund names, share counts, latest tracked quarter, and position changes when available.

Is SILO research on Rallies investment advice?

No. Rallies provides research, data, and educational context for SILO. It does not provide personalized investment advice.

SILO (Silo Pharma, Inc. Common Stock) Stock Analysis - Hedge Fund Holdings

Silo Pharma, Inc. Common Stock (SILO) is a publicly traded Healthcare sector company. As of May 21, 2026, SILO trades at $0.37 with a market cap of $6.31M and a P/E ratio of -0.76. SILO moved -0.13% today. Year to date, SILO is +5.20%; over the trailing twelve months it is -23.78%. Its 52-week range spans $0.22 to $3.37. Rallies surfaces SILO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns SILO stock?

Hedge funds tracked by Rallies that own SILO include Renaissance Technologies and Two Sigma. The latest tracked quarter is Dec 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Silo Pharma, Inc. Common Stock.

SILO Key Metrics

Key financial metrics for SILO
Metric	Value
Price	$0.37
Market Cap	$6.31M
P/E Ratio	-0.76
EPS	$-0.50
Dividend Yield	0.00%
52-Week High	$3.37
52-Week Low	$0.22
Volume	0
Avg Volume	0
Revenue (TTM)	$72.10K
Net Income	$-4.23M
Gross Margin	38.57%

Top Hedge Funds Holding SILO

Renaissance Technologies holds 37.50K shares of SILO, changed -83.48% as of Dec 31, 2024.
Two Sigma holds 11.38K shares of SILO, changed -11.05% as of Dec 31, 2024.

Latest SILO News

Silo Pharma Seeks Patent for Ibogaine TBI Therapy in $6B Market — May 7, 2026
SNDL Q1 Revenue Drops 4.4% with $9.1M Loss; Vireo to Acquire FLUENT — May 4, 2026
FDA Grants Noribogaine IND and ARPA-H Awards Validate Silo Pharma’s PTSD Program — Apr 29, 2026
Silo Pharma Buys Qwikagents.ai, Targets $47–$53B AI Agent Market — Apr 22, 2026
Silo Pharma’s SPC-15 Intranasal PTSD Program Advances Under 505(b)(2) Pathway After Executive Order — Apr 20, 2026

Recent SILO Insider Trades

Weisblum Eric bought 2.50K (~$1.02K) on Dec 15, 2025.
Weisblum Eric bought 2.50K (~$1.05K) on Dec 15, 2025.
Weisblum Eric bought 1.00K (~$365) on Nov 21, 2025.

SILO Analyst Consensus

SILO analyst coverage data. Average price target: $0.00.

Common questions about SILO

Who owns SILO stock?: Hedge funds tracked by Rallies that own SILO include Renaissance Technologies and Two Sigma. The latest tracked quarter is Dec 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Silo Pharma, Inc. Common Stock.
Does Rallies show 13F holders for SILO?: Yes. Rallies tracks hedge fund and 13F ownership data for SILO, including fund names, share counts, latest tracked quarter, and position changes when available.
Is SILO research on Rallies investment advice?: No. Rallies provides research, data, and educational context for SILO. It does not provide personalized investment advice.